{"id":788,"date":"2026-05-23T01:05:50","date_gmt":"2026-05-23T01:05:50","guid":{"rendered":"https:\/\/manarapanuifoundation.org\/?page_id=788"},"modified":"2026-05-24T01:55:20","modified_gmt":"2026-05-24T01:55:20","slug":"rapamycin","status":"publish","type":"page","link":"https:\/\/manarapanuifoundation.org\/es_ES\/rapamycin\/","title":{"rendered":"Rapamycin"},"content":{"rendered":"\n
\"Rapamycin<\/figure>\n\n\n\n

Ra’au Henua<\/h1>\n\n\n\n

“MEDICINE OF THE LAND” \u00b7 RAPAMYCIN & RAPA NUI<\/strong><\/p>\n\n\n\n

Rapamycin \u2014 one of the most influential compounds in modern medicine \u2014 was discovered in the soil of Rapa Nui and carries the island’s name around the world. Yet the community whose land yielded it has never shared in its benefit.<\/p>\n\n\n\n

\n\u2b07 Download the White Paper<\/a>\n\u2764 Donate Now<\/a>\n<\/div>\n\n\n\n
\n\n\n\n

An Opportunity for Reciprocity<\/h2>\n\n\n\n

Rapamycin underpins organ transplantation, oncology, and the fastest-growing area of aging research. The molecule launched a multibillion-dollar field of medicine and bears the Indigenous name of the island where it was found. Today, however, residents of Rapa Nui face persistent gaps in healthcare infrastructure, elder care, and access to basic assistive and medical devices.<\/p>\n\n\n\n

Through Ra’au Henua, the Mana Rapa Nui Foundation invites pharmaceutical, biotechnology, and longevity-sector partners to help close this gap with a transparent, ESG-aligned model that links scientific heritage to measurable community impact \u2014 delivering assistive equipment now, and building a Wellness & Longevity Center on the island over time.<\/p>\n\n\n\n

\n
\n
1964<\/div>\n
Year the source soil was collected on Rapa Nui<\/div>\n <\/div>\n
\n
~7,750<\/div>\n
Island residents served<\/div>\n <\/div>\n
\n
2<\/div>\n
Phases: equipment now, Wellness Center next<\/div>\n <\/div>\n<\/div>\n\n\n\n

The Origin Story<\/h2>\n\n\n\n

In November 1964, roughly forty doctors and scientists set sail from Halifax, Nova Scotia, aboard a Royal Canadian Navy vessel bound for Rapa Nui. The mission \u2014 the Medical Expedition to Easter Island (METEI), backed by the World Health Organization \u2014 aimed to study the island’s people and environment before a newly built airstrip would connect this remarkably isolated community to the wider world.<\/p>\n\n\n\n

Among the team was University of Montreal microbiologist Georges N\u00f3gr\u00e1dy, who gathered more than two hundred soil samples across the island. One sample reached the Ayerst pharmaceutical laboratories in Montreal, where biochemist Surendra “Suren” Sehgal and bacteriologist Claude V\u00e9zina isolated a bacterium \u2014 Streptomyces hygroscopicus<\/em> \u2014 that produced a powerful new molecule. They named it rapamycin, after Rapa Nui.<\/p>\n\n\n\n

The compound nearly disappeared. When Ayerst closed its Montreal facility, the program was slated for cancellation and the samples for destruction. Convinced of its value, Sehgal preserved a sample at home until research could resume \u2014 an act of persistence that ultimately brought rapamycin to market in the late 1990s. From the soil of one of Earth’s most remote islands, a global medicine was born.<\/p>\n\n\n\n

Scientific Importance<\/h2>\n\n\n\n

Rapamycin \u00b7 C\u2085\u2081H\u2087\u2089NO\u2081\u2083<\/strong><\/p>\n\n\n\n

Rapamycin’s first major role was as an immunosuppressant: approved in the late 1990s as sirolimus (Rapamune), it became essential in preventing organ-transplant rejection and in drug-eluting coronary stents. Its deeper significance lies in how it works \u2014 by inhibiting a master regulatory pathway named after the drug itself, mTOR (the mechanistic target of rapamycin), which governs cell growth, metabolism, and survival. This has made rapamycin one of the most studied molecules in biology and a central tool in the science of aging.<\/p>\n\n\n\n

An honest view of the longevity evidence<\/h3>\n\n\n\n

In animal studies, reducing mTOR activity has extended lifespan, and an overactive mTOR pathway is linked to many age-related conditions. In the interest of credibility, we state the evidence plainly: as of 2025, the dramatic lifespan results seen in animals have not yet been demonstrated in healthy humans. Early clinical trials suggest low-dose rapamycin can be reasonably well tolerated and may produce modest changes in markers of biological aging, but long-term human benefits remain unproven, and larger trials are needed.<\/p>\n\n\n\n

\n

WHY THIS MATTERS TO PARTNERS<\/p>\n

This initiative does not depend on rapamycin’s longevity promise being proven. It rests on the molecule’s established scientific stature and its undisputed origin in Rapa Nui. Honesty about the science strengthens \u2014 rather than weakens \u2014 a partner’s reputational position.<\/p>\n<\/div>\n\n\n\n

The Ethical Gap \u2014 and a Leadership Opportunity<\/h2>\n\n\n\n

A molecule drawn from Rapa Nui’s soil launched a major pharmaceutical industry and an entire field of research. Yet the people of Rapa Nui shared in none of its proceeds, and many islanders today lack access to basic assistive devices and medical equipment.<\/p>\n\n\n\n

This is not a grievance the Foundation invented; it is a question now being raised within the scientific community itself \u2014 what researchers and companies owe the Indigenous communities and lands from which discoveries are drawn. We frame this not as a debt to be demanded, but as a leadership opportunity: a chance for a forward-looking partner to be the organization that closes the loop, connecting scientific heritage to tangible benefit for the originating community.<\/p>\n\n\n\n

The Solution: A Two-Phase Initiative<\/h2>\n\n\n\n
\n
\n

PHASE 1 \u00b7 IMMEDIATE<\/p>\n

Assistive Equipment Deployment<\/h3>\n

Direct delivery of wheelchairs, walkers, mobility aids, and essential medical devices to islanders and elders who currently lack them. Fast, visible, measurable impact.<\/p>\n

Target: [ X wheelchairs, Y walkers, Z devices ] within [ 12 months ]. Estimated cost: [ $ amount ].<\/p>\n <\/div>\n

\n

PHASE 2 \u00b7 LONG-TERM<\/p>\n

Wellness & Longevity Center<\/h3>\n

A permanent center on Rapa Nui integrating healthcare delivery, elder care, and sustainable operations \u2014 a lasting institution that honors the island’s heritage as a place of healing.<\/p>\n

Scope: [ facility size \/ services ]. Estimated cost: [ $ amount ].<\/p>\n <\/div>\n<\/div>\n\n\n\n

\n“The molecule carries the name of Rapa Nui worldwide. This initiative ensures its legacy returns through measurable impact.”\n<\/blockquote>\n\n\n\n

Partnership & Investment Structure<\/h2>\n\n\n\n\n \n \n \n \n \n \n
PARTNERSHIP TIER<\/th>\n COMMITMENT<\/th>\n ILLUSTRATIVE BENEFITS<\/th>\n <\/tr>\n <\/thead>\n
Flagship Partner<\/td>\n $1M+<\/td>\n Naming opportunity, leadership role on initiative, premier recognition, executive engagement.<\/td>\n <\/tr>\n
Strategic Partner<\/td>\n $500K \u2013 $1M<\/td>\n Prominent recognition, program co-branding, impact reporting and engagement.<\/td>\n <\/tr>\n
Supporting Partner<\/td>\n $100K \u2013 $500K<\/td>\n Named recognition, impact updates, acknowledgment across Foundation channels.<\/td>\n <\/tr>\n <\/tbody>\n<\/table>\n

Tier benefits are illustrative and confirmed in a written partnership agreement. Naming and recognition opportunities are offered at the Foundation’s discretion.<\/p>\n\n\n\n

Join Ra’au Henua<\/h2>\n\n\n\n

Read the full investor & strategic partnership white paper, or support the work directly.<\/p>\n\n\n\n

\n\u2b07 Download the White Paper<\/a>\n\u2764 Donate Now<\/a>\n<\/div>\n\n\n\n
\n\n\n\n

Mana Rapa Nui Foundation<\/strong> \u2014 501(c)(3) Nonprofit Organization \u00b7 Durham, North Carolina, USA
EIN [ EIN number ] \u00b7 Partnerships: [ partnerships@… ] \u00b7 manarapanuifoundation.org<\/a><\/p>\n\n\n\n

Scientific statements reflect the state of published evidence as of 2026 and are informational only; rapamycin is not approved as an anti-aging therapy. This page is for partnership discussion and does not constitute an offer of securities or investment advice.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Ra’au Henua “MEDICINE OF THE LAND” \u00b7 RAPAMYCIN & RAPA NUI Rapamycin \u2014 one of the most influential compounds in modern medicine \u2014 was discovered in the soil of Rapa Nui and carries the island’s name around the world. Yet the community whose land yielded it has never shared in its benefit. \u2b07 Download the […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"full-width","meta":{"saved_in_kubio":false,"footnotes":""},"class_list":["post-788","page","type-page","status-publish","hentry"],"aioseo_notices":[],"kubio_ai_page_context":{"short_desc":"","purpose":"general"},"_hostinger_reach_plugin_has_subscription_block":false,"_hostinger_reach_plugin_is_elementor":false,"_links":{"self":[{"href":"https:\/\/manarapanuifoundation.org\/es_ES\/wp-json\/wp\/v2\/pages\/788","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/manarapanuifoundation.org\/es_ES\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/manarapanuifoundation.org\/es_ES\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/manarapanuifoundation.org\/es_ES\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/manarapanuifoundation.org\/es_ES\/wp-json\/wp\/v2\/comments?post=788"}],"version-history":[{"count":13,"href":"https:\/\/manarapanuifoundation.org\/es_ES\/wp-json\/wp\/v2\/pages\/788\/revisions"}],"predecessor-version":[{"id":822,"href":"https:\/\/manarapanuifoundation.org\/es_ES\/wp-json\/wp\/v2\/pages\/788\/revisions\/822"}],"wp:attachment":[{"href":"https:\/\/manarapanuifoundation.org\/es_ES\/wp-json\/wp\/v2\/media?parent=788"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}